The Journal of Bone and Joint Surgery Published Article Shows Smith+Nephew’s OXINIUM on XLPE for Total Hip Arthroplasty as Best Performing Bearing Beyond 10 Years

Smith+Nephew today announced the publication of new clinical evidence further validating the exceptional performance of its proprietary OXINIUM on XLPE (highly cross-linked polyethylene) for total hip arthroplasty (THA). The publication in The Journal of Bone and Joint Surgery Open Access analyses data from the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man (NJR) and concludes that THA procedures using OXINIUM on XLPE were associated with the lowest risk of revision of all bearing combinations for any reason beyond 10 years.1

This analysis of more than 400,000 THAs* confirms that procedures using OXINIUM on XLPE showed:

  • 1.96% cumulative incidence of revision at 10 years1 compared with the average of 4.79% for primary hip replacements.2
  • 48% reduction in risk for aseptic loosening compared to metal on XLPE.1
  • Lowest revision risk vs. all bearing combinations in patients less than 55 years old.1
  • Lower risk of revision compared to ceramic-on-ceramic hip bearing combinations.1 
                      
    (*based on UK NJR data analysis of cementless and hybrid THA data.1)

“Total hip arthroplasty using a bearing combination of OXINIUM on XLPE versus traditional ceramic or metal constructs results in greatly improved survivorship and significantly reduced the need for revision,” said Prof. Edward T. Davis FRCS, of The Royal Orthopaedic Hospital NHS Foundation Trust. “Even in the younger more active patients, the results are spectacular, and I am excited to continue using OXINIUM on XLPE to deliver better outcomes for my patients.”

The new analysis of NJR data corroborates a similar report from the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR), and publications referencing the Italian Registry (RIPO; Register of Orthopaedic Prosthetic Implants) and the Dutch Arthroplasty Register (LROI), which all confirm the positive effect that modern bearing surface combinations like OXINIUM on XLPE have on THA survival.3,4,5

“Registries throughout the world have highlighted the performance of OXINIUM for total hip arthroplasty. This publication is further evidence of the success of our truly differentiated and proven technology,” said Skip Kiil, President of Global Orthopaedics at Smith+Nephew. “THA is considered one of the most clinically successful procedures in modern medicine, and OXINIUM on XLPE continues to raise the bar for acceptable revision rates.”


References

  1. Davis ET, Pagkalos J, Kopjar B. Effect of Bearing Surface on Survival of Cementless and Hybrid Total Hip Arthroplasty. JBJS Open Access. 2020;5(2): e0075. doi:10.2106/jbjs.oa.19.00075
  2. National Joint Registry for England, Wales, Northern Ireland and the Isle of Man: 16th Annual Report 2019. Available at: https://reports.njrcentre.org.uk. Accessed 5 February 2019.
  3. Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) Hip, Knee & Shoulder Arthroplasty: 2019 Annual Report. Available at: https://aoanjrr.sahmri.com/annual-reports-2019. Accessed 22 November 2019.
  4. Atrey A, Ancarani C, Fitch D, Bordini B. Impact of bearing couple on long-term component survivorship for primary cementless total hip replacement in a large arthroplasty registry. Poster presented at: Canadian Orthopedic Association; June 20–23, 2018; Victoria, British Columbia, Canada.
  5. Peters RM, Van Steenbergen LN, Stevens M, Rijk PC, Bulstra SK, Zijlstra WP. The effect of bearing type on the outcome of total hip arthroplasty. Acta Orthop. 2018;89(2):163–169. doi:10.1080/17453674.2017.1405669
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy